Dr. Norman Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 23-10-2024
- Paid Up Capital ₹ 0.90 M
as on 23-10-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -23.15%
(FY 2023)
- Ebitda -26.48%
(FY 2023)
- Net Worth -250.72%
(FY 2023)
- Total Assets -25.03%
(FY 2023)
About Dr. Norman Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Devarajan Govindarajulu, Krishnamurthy, and Kuppusamy Ramadas serve as directors at the Company.
- CIN/LLPIN
U74900TN2011PTC082793
- Company No.
082793
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr. Norman Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devarajan Govindarajulu  | Director | 19-Oct-2011 | Current |
| Krishnamurthy | Director | 19-Oct-2011 | Current |
Kuppusamy Ramadas  | Director | 19-Oct-2011 | Current |
Financial Performance of Dr. Norman Laboratories.
Dr. Norman Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 23.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 250.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Norman Laboratories?
In 2023, Dr. Norman Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Middle Mist Pharmaceuticals Private LimitedActive 9 years 4 months
Kuppusamy Ramadas is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Norman Laboratories?
Unlock and access historical data on people associated with Dr. Norman Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Norman Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Norman Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
